Evidence map›Paper›PMID 42412783›Full record

ArticleBioinformatics (Oxford, England)2026

Agentomics: an agentic system that autonomously develops novel state-of-the-art solutions for biomedical machine learning tasks.

Vlastimil Martinek, Andrea Gariboldi, Dimosthenis Tzimotoudis, Mark Galea, Elissavet Zacharopoulou, Aitor Alberdi Escudero, Edward Blake, David Čechák, Luke Cassar, Alessandro Balestrucci and 1 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vlastimil MartinekCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Andrea GariboldiCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Dimosthenis TzimotoudisCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Mark GaleaCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Elissavet ZacharopoulouCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Aitor Alberdi EscuderoCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Edward BlakeCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
David ČechákCentral European Institute of Technology, Masaryk University, Brno, 625 00, Czech Republic.
Luke CassarCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Alessandro BalestrucciCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.
Panagiotis AlexiouCentre for Molecular Medicine and Biobanking, University of Malta, Msida, MSD 2080, Malta.ORCID 0000-0003-3437-7482

Funding

2022 BioGeMT 101086768Bioinformatics Core Facility of CEITEC Masaryk UniversityHORIZONHORIZON-EIC-2022-Pathfinderchallenges-01-03 TargetMI 101114924Ministry of Education, Youth and Sports of the Czech RepublicNational Center for Molecular Genomics LM2023067University of Malta's Data Integrity and Stewardship ClusterWIDERA
6 · The paper itself

Abstract

motivationExtracting knowledge from biomedical data is crucial for advancing our understanding of biological systems and developing novel therapeutics. The quantity, quality, and resolution of biomedical data constantly evolves, requiring the automation of biomedical machine learning (ML). Existing Automated ML tools lack flexibility, while large language models (LLMs) struggle to consistently deliver reproducible machine learning codebases, and existing LLM Agent-powered solutions lag behind human-engineered ML models.

resultsHere, we introduce Agentomics, an autonomous LLM-powered agentic system for end-to-end ML experimentation. Given a biomedical dataset, Agentomics implements various ML modeling strategies, and produces a ready-to-use ML model. Agentomics introduces strict validation checkpoints for standard ML development steps, allowing gradual development on top of working code with defined interfaces and validated artifacts. Further, it offers native support for biomedical foundation models that can be leveraged during experimentation. The generic nature of Agentomics allows the user to create ML solutions for a large variety of datasets and use various LLMs. We evaluate Agentomics across 20 datasets from the domains of Protein Engineering, Drug Discovery, and Regulatory Genomics. When benchmarked against other agentic systems, Agentomics outperformed them in all tested domains. When benchmarked against human expert solutions, Agentomics generated novel state-of-the-art models for 11/20 established benchmark datasets. AVAILABILITY AND IMPLEMENTATION: Agentomics is implemented in Python. Source code and documentation are freely available at: https://github.com/BioGeMT/Agentomics-ML.

Indexed as

Computational BiologyMachine LearningHumansLarge Language ModelsSoftware

Identifiers

PMID42412783
PMCPMC13340167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.